Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
NCT00234689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2008-01-30
Summary
Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD
Conditions
- Obsessive Compulsive Disorder
Interventions
- DRUG
-
Naltrexone
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Joseph Zohar, MD · Tel Aviv University
-
Revital Amiaz, MD · Tel Aviv University
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-01-31
- Primary Completion
- 2004-12-31
- Completion
- 2004-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
NCT01108393 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety
NCT03346239 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder
NCT04693351 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Inhibitory Control Training for Compulsive Behavior Change
NCT03682913 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Nitrous Oxide in OCD: Pilot Study
NCT03826693 ·Status: RECRUITING ·Phase: PHASE2
-
Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
NCT00464698 ·Status: COMPLETED ·Phase: PHASE4
-
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
NCT00254735 ·Status: COMPLETED ·Phase: PHASE3
-
Fear Conditioned Response in Healthy Subjects and in OCD Patients Pre and Post Treatment With Sertraline.
NCT03068429 ·Status: COMPLETED ·Phase: PHASE4
-
OCD Among Patients With Burns
NCT00294983 ·Status: WITHDRAWN
-
Short Term Group Therapy for Anxiety Disorder
NCT00229281 ·Status: COMPLETED ·Phase: NA
-
Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
NCT00299611 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
NCT04708834 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating the Effects of a Computerized Training Program Coupled With Cognitive Behavioral Therapy (CBT) for OCD.
NCT03855943 ·Status: UNKNOWN ·Phase: NA
-
Treatment Youth With Obsessive-Compulsive Disorder
NCT00708240 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
NCT04882839 ·Status: RECRUITING ·Phase: PHASE2
-
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
NCT05940324 ·Status: RECRUITING ·Phase: PHASE2
-
Unilateral Deep Brain Stimulation (DBS) of the Nucleus (Nucl.) Accumbens (Acc.) in Patients With Treatment Resistant Obsessive Compulsive Disorder (OCD)
NCT00724490 ·Status: COMPLETED ·Phase: NA
-
Discovering Factors in the Clinical Study Journey of Patients With OCD
NCT05881356 ·Status: RECRUITING
-
Understanding How Ketamine Brings About Rapid Improvement in OCD
NCT02624596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder
NCT05995951 ·Status: RECRUITING ·Phase: NA
-
Ondansetron Augmentation in Treatment-resistant OCD
NCT01303536 ·Status: COMPLETED ·Phase: PHASE4
-
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
NCT00035438 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Unilateral Deep Brain Stimulation in Patients With Obsessive Compulsive Disorder
NCT03894397 ·Status: COMPLETED ·Phase: NA
-
Attentional Bias Modification Treatment in OCD
NCT02014194 ·Status: COMPLETED ·Phase: NA
-
Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment
NCT00466609 ·Status: COMPLETED ·Phase: PHASE4